Research progress in the treatment of retinoblastoma

Research progress in the treatment of retinoblastoma

Retinoblastoma(RB)is the most common intraocular malignant tumor in infants, the pathogenesis of which, is related to gene mutations. In order to improve the survival rate and eye-protection rate of RB patients, the therapeutic approaches have been constantly updated and developed, mainly including...

Full description

Bibliographic Details
Main Authors: Hong-Mi Zou, Jia Jian, Xi-Yuan Zhou
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2018-08-01
Series:Guoji Yanke Zazhi
Subjects:
retinoblastoma
treatment
Online Access:http://ies.ijo.cn/cn_publish/2018/8/201808011.pdf
id doaj-470b8c366a0d45c18acd0d3b3b04da6b
record_format Article
spelling doaj-470b8c366a0d45c18acd0d3b3b04da6b2020-11-24T23:08:36ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51231672-51232018-08-011881407141010.3980/j.issn.1672-5123.2018.8.11Research progress in the treatment of retinoblastomaHong-Mi Zou0Jia Jian1Xi-Yuan Zhou2Department of Ophthalmology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, ChinaDepartment of Ophthalmology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, ChinaDepartment of Ophthalmology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, ChinaRetinoblastoma(RB)is the most common intraocular malignant tumor in infants, the pathogenesis of which, is related to gene mutations. In order to improve the survival rate and eye-protection rate of RB patients, the therapeutic approaches have been constantly updated and developed, mainly including chemotherapy, radiation therapy, surgical treatment, physiotherapy, photochemotherapy, gene therapy at present. In this article, we mainly reviewed the progress of RB treatment.http://ies.ijo.cn/cn_publish/2018/8/201808011.pdfretinoblastomatreatmenttreatment
collection DOAJ
language English
format Article
sources DOAJ
author Hong-Mi Zou
Jia Jian
Xi-Yuan Zhou
spellingShingle Hong-Mi Zou
Jia Jian
Xi-Yuan Zhou
Research progress in the treatment of retinoblastoma
Guoji Yanke Zazhi
retinoblastoma
treatment
treatment
author_facet Hong-Mi Zou
Jia Jian
Xi-Yuan Zhou
author_sort Hong-Mi Zou
title Research progress in the treatment of retinoblastoma
title_short Research progress in the treatment of retinoblastoma
title_full Research progress in the treatment of retinoblastoma
title_fullStr Research progress in the treatment of retinoblastoma
title_full_unstemmed Research progress in the treatment of retinoblastoma
title_sort research progress in the treatment of retinoblastoma
publisher Press of International Journal of Ophthalmology (IJO PRESS)
series Guoji Yanke Zazhi
issn 1672-5123
1672-5123
publishDate 2018-08-01
description Retinoblastoma(RB)is the most common intraocular malignant tumor in infants, the pathogenesis of which, is related to gene mutations. In order to improve the survival rate and eye-protection rate of RB patients, the therapeutic approaches have been constantly updated and developed, mainly including chemotherapy, radiation therapy, surgical treatment, physiotherapy, photochemotherapy, gene therapy at present. In this article, we mainly reviewed the progress of RB treatment.
topic retinoblastoma
treatment
treatment
url http://ies.ijo.cn/cn_publish/2018/8/201808011.pdf
work_keys_str_mv AT hongmizou researchprogressinthetreatmentofretinoblastoma
AT jiajian researchprogressinthetreatmentofretinoblastoma
AT xiyuanzhou researchprogressinthetreatmentofretinoblastoma
_version_ 1725613358822981632

Similar Items